SEC Form 4 · accession 0000899243-18-023080
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $14.08 | Aug 20, 2018 | A | 75,000 | A | — | Aug 20, 2028 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period.